Drug company sponsorship of academic conferences unpopular? Doctors want to clean up the academic conference environment!
A few days ago, in Shijiazhuang, Hebei Province, Taixing State Hotel held the "Third Academic Conference on Pancreatic Diseases in Hebei Province and Digestive and Gastrointestinal Endoscopy Standard Diagnosis and Treatment Seminar" (hereinafter referred to as the seminar), not only the whole process is full of drug advertising, the organizers are openly for a drug "stand", to many primary care doctors to preach the efficacy of a drug, the seriousness of the meeting was questioned by many participating doctors.
The reporter found that drug companies and pharmaceutical companies sponsor medical conferences in China has become the norm. In order to regulate the practice of doctors and academic exchange behavior, the former National Health Planning Commission and the Chinese Medicine Administration jointly developed and released the "Strengthening the construction of medical and health care practices "nine no"", a number of provinces have introduced relevant measures, but many medical academic conference and drug companies, drug companies between the relationship is still "ambiguous ". In this regard, many doctors expressed the hope that the environment of academic conferences can be purified.
2026-10-13
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
What do pharmaceutical companies look forin the rare disease field?
-
What Are The Top Selling Generic Drugs In 2018?
-
24.6 Down To $0.84! A Batch Of Reduced-Price Drugs Are Now Available In Pharmacies
-
China Small Molecule Innovative Drugs Industry Trends to 2022
-
FDA approves Merck's new drug Belzutifan
-
Active R&D and strong demand for innovative peptide drugs
-
Anxious drug company bosses pile on innovative drugs
-
Children's medicine 'legalization' to accelerate the layout of drug companies
-
Original drug market: The prices of upstream raw materials remain high, and downstream small businesses are under great pressure to survive!
-
Middle East Polyolefins Hit by Catalyst Constraints: PE/PP Recovery May Be Slower
Recommend Reading
-
Guangxi Huayi Starts 300,000-Tonne VAM Unit: EVA Chain Keeps Expanding
-
GM Crop Area Hits 216 Million Hectares: Trait-Driven Farming Expands
-
Snack Tests Put Red 40, Titanium Dioxide and BHT Back Under Pressure
-
When SWIFT Goes On-Chain: A New 24/7 Order for Cross-Border Payments
-
Behind the Three Consecutive Titanium Dioxide Price Hikes, Sulfur and Sulfuric Acid Costs Are Rewriting the Pricing Floor
-
This week, the TDI market in China showed a strong upward trend (11.10-11.14)
-
This week, caustic soda prices remain firm (3.23-3.27)
-
This Week's Styrene Market First Declined Then Rose (11.10-11.14)
-
Insufficient Downstream Demand, DMF Market Primarily Ranges Within a Narrow Band
-
Bulls and Bears in a Tight Spot: ABS Rides Out High Levels at End of March